The University of Chicago Header Logo

Connection

Ravi Salgia to Antibodies, Neutralizing

This is a "connection" page, showing publications Ravi Salgia has written about Antibodies, Neutralizing.
Connection Strength

0.030
  1. Overcoming acquired resistance to cetuximab by dual targeting HER family receptors with antibody-based therapy. Mol Cancer. 2014 Oct 24; 13:242.
    View in: PubMed
    Score: 0.030
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.